Latest news with #ChinaChamberof
Business Times
3 days ago
- Business
- Business Times
Chinese firms warn EU procurement curb could hurt trade ties
[BEIJING] A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a Monday (Jun 2) statement from the Chinese group. 'Its targeted application against Chinese enterprises sends a troubling signal-not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early this month in Paris, where he may address the bloc's trade grievances including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit next month with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices last April, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG
Straits Times
3 days ago
- Business
- Straits Times
Chinese firms warn EU procurement curb could hurt trade ties
The dispute threatens to add another irritant to relations between Beijing and the EU. PHOTO: REUTERS BEIJING – A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a statement from the Chinese group on June 2. 'Its targeted application against Chinese enterprises sends a troubling signal – not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early in June in Paris, where he may address the bloc's trade grievances, including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit in July with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices in April 2024, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.
Yahoo
21-05-2025
- Business
- Yahoo
HNC Shanghai This June to Reshape the Blueprint of the Health Industry
Breakthrough Across Borders • Innovation Beyond Boundaries SHANGHAI, May 20, 2025 /PRNewswire/ -- Jointly organized by the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and Sinoexpo Informa Markets, the "Healthplex Expo 2025, Natural & Nutraceutical Products China 2025" (HNC 2025) will be grandly held at the National Exhibition and Convention Center (Shanghai) from June 24 to 26, 2025. As China's health consumption trends shift from a focus on physical well-being to holistic mental and emotional wellness, HNC 2025 embraces the theme "Driving Innovation & Navigating Health", reflecting the industry's transformation. HNC will spotlight the reconstruction of global supply chains and the evolution of domestic health consumption, uniting exhibitions of Hi & Fi Asia-China, ProPak China & FoodPack China, etc. Together, they will create a comprehensive international trade platform spanning over 200,000 square meters, redefining the landscape of the health industry. Opening New Cross-Border Trade Routes In the face of the restructuring of global supply chains, HNC continues to serve as a vital international business platform for the global health industry, having always focused on expanding the domestic consumer market and enabling domestic and overseas companies to efficiently connect with high-quality domestic resources. In 2025, HNC will welcome the Italian pavilion for the first time, as well as the Australian pavilion who has been deeply involved in the Chinese market for many years. Furthermore, the 2025 edition will once again attract exhibitors from over 30 countries and regions, including Korea, Japan, Malaysia, Singapore, New Zealand, the United States, Spain, Belgium, and Norway. Industry giants such as BLACKMORES, BLUEGUM PHARMACEUTICALS, FPA GROUP, HOMART GROUP, LAVIDA PHARMACEUTICALS, LIPA PHARMACEUTICALS, COSMAX NBT, KOLMAR BNH, UNIPHARM, IFF, SUHEUNG, NOVAREX, NATAC PTE, INVAPHARM, API, ROBINSON, and LAMBO LABORATORIES will showcase their latest innovations on-site. A highlight of the exhibition will be the 14th Nutraceutical Industry Development Conference (NIDC), which will introduce a new theme on "Counter-Cyclical Growth." Government officials and leading experts will be invited to interpret the latest regulations and policies on health product import/export, and to provide insights on how enterprises can respond to tariff and trade policy challenges. What's more, HNC will provide exclusive opportunities for overseas brands to host roadshows, with the participation of professional buyers, to overcome the difficulties faced by overseas SMEs in entering the Chinese market. Decoding the New Paradigm of Health Consumption Notably, the breakthrough in cross-border trade is resonating with an ongoing wave of domestic consumption upgrades. In China, consumer health trends such as light tonic supplementation, healing and wellness, and weight management are reshaping the market landscape. According to the China Health Food Consumption Trend Report, products rooted in the "medicine-food homology" concept are experiencing a compound annual growth rate of 24.3%. Among these, categories such as ready-to-eat donkey-hide gelatin snacks and ginseng honey slices—key examples of "light tonics"—boast repurchase rates exceeding 35% among younger consumers. In response, HNC will closely follow these evolving trends by launching a dedicated zone for Medicinal & Food Homologous Products, bringing together over 30 pioneering brands including YUNNAN BAIYAO, TONG REN TANG HEALTH, QINGYUNSHAN PHARMACEUTICAL, HONGSHOU BIO-TECH, GUOHETANG, ZHI SHEN TANG, SUNOTA, GANOHERB, XIANZHILING, BEIDA CISTANCHE, HENGCHUNTANG, and HUIBAITANG. Exhibitors will unveil next-generation product formats such as snackable nutrition packs and personalized tonic solutions. For the first time in 2025, HNC will debut a thematic zone titled "Vitality Hub", which will feature a deep integration of two flagship experiential events: the Healing Lifestyle Festival and the Light Wellness Tea Awakening Festival. The Healing Lifestyle Festival pioneers a full-circle experience around the emerging "olfactory economy," with exhibits spanning emotional wellness, essential oils and hydrosols, aromatherapy, organic skincare, clean beauty, and botanical personal care. Attendees can immerse themselves in an aromatherapy micro garden and participate in custom scent workshops to create their own mood-based essential oil blends. The concurrently held Natural Fragrance Industry Development Forum will decode the fundamental growth logic behind the burgeoning scent economy. Echoing this theme, the Light Wellness Tea Awakening Festival aims to reinvent the health beverage ecosystem. This immersive showcase features a wide variety of products, including health teas, functional drinks, plant-based beverages, cold brew teas, fermented blends, and healthy light meals. Whether visitors are devoted to traditional health practices or exploring trendy wellness lifestyles, they'll discover offerings that suit their personal needs and taste. Beyond these new zones, HNC continues to gather cutting-edge products across multiple categories—ranging from immune enhancement, anti-aging solutions, cardiovascular health, gut microbiome modulation, and weight management to therapeutic beauty. The exhibitors in 2025 will include SIRIO, SENLAN, BIOHIGH, IVC, CALTURE, BRAVEIY, BIOBOR, HENGMEI, DAMIN, CAXIN, GENLAI, DAILY NUTRITION, NUSPOWER GREATSUN, INATURAL BIOTECH, TBH, ERA, LITHY, YICHAO, JIANTE, FTCM, SINO PEPTIDE, JILDAN, YOUNENG, NUTRYFARM, TRACE ELEMENT, and more than 500 leading enterprises in the health field, exhibiting their new products, best-selling lines and solutions. HNC 2025 will present an overview of the industry's upgrade from fundamental nutrition to personalized precision health management. Unlocking New Multichannel Trade Opportunities Amidst the ongoing transformation of sales channels driven by the rise of the "lazy economy," HNC will host a series of targeted events on-site, including the e-commerce innovation forum, the product matchmaking activity for new e-commerce channels, and the innovative marketing conference, etc. These events will bring together top-tier influencers from platforms such as Rednote and Douyin, as well as leading KOLs from major e-commerce ecosystems. The representatives from well-known MCN agencies will make special appearances to select products of trending categories such as cross-border healthy snacks, beauty-focused oral supplements, and functional foods for weight management. In addition, the business matchmaking for supermarket chains & pharmacy chains will provide exhibitors with direct access to procurement representatives from leading national and regional supermarkets and pharmacies, aiming to build a comprehensive offline distribution network. Capturing Emerging Drivers of Industry Growth As a leading hub for both policy and technology, HNC will host over 70 high-level forums and activities onsite, bringing together government agencies, industry associations, and specialized media. These events will offer an all-round agenda covering policy interpretations sessions, technical seminars, market insights, new product launches, business matchmaking, etc. On the regulatory front, the 9th Forum on Foods for Special Medical Purpose will provide in-depth insights into the latest approval and registration policies for FSMPs (Foods for Special Medical Purposes), while the 7th Forum on Nutrition and Special Foods will focus on the clinical trial data for FSMPs. In cutting-edge technology, the 2025 National Forum on Low GI, Whole-Grain and Plant-Based Health Foods will unveil new solutions for metabolic health management, and the Insight Conference on MFH Products will explore the fusion of traditional Chinese medicinal ingredients and snackification technologies. Focusing on niche verticals, the 2025 Weight Management Product Innovation Insight Conference will delve into the transition of light foods toward precision nutrition. The Family Nutrition Trend Insight and Innovative Solution Forum 2025 will address tailored nutritional solutions for seniors and children, while the New Nutrition Full Life Cycle Focus Summit 2025 will inject vitality into the industry through forward-looking market insights, robust scientific validation, and novel product strategies. Meanwhile, the 2025 China Jilin Ginseng Health (Shanghai) Forum will spotlight ginseng's pivotal role in advancing national health and explore its global integration. Other specialized sessions include forums on pet nutrition certification, clean label development, and the growth of Shanghai's health-focused retail sector. From June 24 to 26, 2025, global leaders of the health industry will convene at the National Exhibition and Convention Center (Shanghai). Anchored in the theme "Breakthrough Across Borders•Innovation Beyond Boundaries", HNC will empower businesses to navigate global trade disruptions, foster local innovation, build diversified commercial networks, and deliver macroeconomic and industry foresight—co-creating a renewed blueprint for the global health economy. CONTACT USSINOEXPO INFORMA MARKETSEmail: Website: HNCEXPO on Facebook / LinkedIn / X View original content: SOURCE Sinoexpo Informa Markets Sign in to access your portfolio
